Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma
NT Madan Mohan,1 Adarsh Gowda,2 Ashok Kumar Jaiswal,1 BC Sharath Kumar,2 P Shilpashree,1 Bilugumba Gangaboraiah,3 Manjula Shamanna4 1Department of Dermatology, Dr BR Ambedkar Medical College (BRAMC), Bangalore, Karnataka, India; 2Department of Dermatology, 3Department of Community Medicine, Kempegow...
Saved in:
Main Authors: | Madan Mohan NT (Author), Gowda A (Author), Jaiswal AK (Author), Sharath Kumar BC (Author), Shilpashree P (Author), Gangaboraiah B (Author), Shamanna M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative study of the efficacy of 4% hydroquinone vs 0.75% Kojic acid cream in the treatment of facial melasma
by: Rochelle C Monteiro, et al.
Published: (2013) -
Fabrication, characterization and transdermal properties of double cross-linked gel beads with 4-n-butylresorcinol
by: Faxin Zhang, et al.
Published: (2024) -
Efficacy of Low-Dose (0.3 mg) Conjugated Estrogen Cream for Managing Atrophic Vaginitis
by: Nungruthai Sinnithithaworn, et al.
Published: (2013) -
Intradermal injection of tranexamic acid combined with topical hydroquinone cream versus topical hydroquinone cream alone in the treatment of melasma
by: Lavan Taha, et al.
Published: (2022) -
Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies
by: Zoe D. Draelos
Published: (2023)